Suchergebnisse - "Asselah, Tarik"

PubPharm (25)

1

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies : A Real-World Experience in France

enthalten in: Digestive diseases and sciences | 2021

von Ouzan, D. | Larrey, D. | Guyader, D. | +49

2

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France

enthalten in: Digestive diseases and sciences | 2020

von Ouzan, D. | Larrey, D. | Guyader, D. | +19

3

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France

enthalten in: Digestive diseases and sciences | 2020

von Ouzan, D. | Larrey, D. | Guyader, D. | +19

4

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France

enthalten in: Digestive diseases and sciences | 2020

von Ouzan, D. | Larrey, D. | Guyader, D. | +19

5

Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection

enthalten in: Journal of viral hepatitis | 2019

von Asselah, T. | Shafran, S. | Bourgeois, S. | +12

6

Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients

enthalten in: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association | 2019

von Babatin, M. | AlGhamdi, A. | Assiri, A. | +6

7

Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use : An integrated analysis of 7 phase III studies

enthalten in: Drug and alcohol dependence | 2019

von Foster, G. | Dore, G. | Wang, S. | +12

8

Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2018

von Asselah, T. | Bourgeois, S. | Pianko, S. | +11

9

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

enthalten in: The New England journal of medicine | 2018

von Zeuzem, S. | Foster, G. | Wang, S. | +35

10

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection : 2 Phase 3 Randomized Trials

enthalten in: Gastroenterology | 2017

von Jacobson, I. | Lawitz, E. | Gane, E. | +27